← Leaderboards
Michael Cohen-Wolkowiez
Duke University
$47,908,561
Attributed
$130,940,787
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $51.5M · FY2010–23$100M$75M$50M$25M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$124,943,868 · 7
FDA$5,996,919 · 2
By mechanism
U24$116,652,802 · 1
U18$5,500,000 · 1
T32$3,864,554 · 2
R01$2,553,940 · 1
K24$895,411 · 1
N01$502,743 · 1
Top collaborators
- Kim L Brouwer8 shared
- Paul B Watkins6 shared
- Daniel K Benjamin4 shared
- Giselle Corbie-Smith4 shared
- Warren A Kibbe4 shared
- Gaurav J Dave3 shared
- Lisa M Wruck3 shared
- Christoph Hornik2 shared
Most similar at Duke University
Same institution · by research overlap
- Tiarney D Ritchwood$7,802,996
- Alisa S Wolberg$13,659,847
- Daniel K Benjamin$109,874,279
- Gaurav J Dave$20,316,071
- Lisa M Wruck$17,165,453
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchResearch InstituteResearch PersonnelChildScienceClinical TrialsSkillsChildhoodData ManagementUniversitiesUnited States National Institutes Of HealthPublic HealthDesignAdultSafetyEnsureResearch InfrastructurePharmaceutical PreparationsDoseFundingTrainingVulnerable PopulationsClinical PharmacologyInfrastructure
Grant awards (39)
RADx-UP CDCC$32,364,105
U24 · FY2023 · MD · contact PI
RADx-UP CDCC$12,729,140
U24 · FY2023 · MD · contact PI
RADx-UP CDCC$2,000,000
U24 · FY2023 · MD · contact PI
Mentoring in Clinical Pharmacology and Early Phase Trials$177,687
K24 · FY2023 · AI · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$710,612
T32 · FY2022 · GM
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$192,030
T32 · FY2022 · HD · contact PI
Mentoring in Clinical Pharmacology and Early Phase Trials$177,687
K24 · FY2022 · AI · contact PI
RADx-UP CDCC$36,243,390
U24 · FY2021 · MD · contact PI
RADx-UP CDCC SAY YES COVID Test Study$7,653,833
U24 · FY2021 · MD · contact PI
RADx-UP SAY YES COVID Test Study (S4)$5,500,000
U24 · FY2021 · MD · contact PI
Global Pediatric Clinical Trials Network$1,000,000
U18 · FY2021 · FD
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$706,465
T32 · FY2021 · GM
Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program$184,040
T32 · FY2021 · HD · contact PI
Mentoring in Clinical Pharmacology and Early Phase Trials$179,085
K24 · FY2021 · AI · contact PI
RADx-UP CDCC$20,162,334
U24 · FY2020 · MD · contact PI
Global Pediatric Clinical Trials Network$1,000,000
U18 · FY2020 · FD
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$550,453
T32 · FY2020 · GM
Global Pediatric Clinical Trials Network$500,000
U18 · FY2020 · FD
Mentoring in Clinical Pharmacology and Early Phase Trials$179,771
K24 · FY2020 · AI · contact PI
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation Supplement$86,400
T32 · FY2020 · GM
Global Pediatric Clinical Trials Network$1,000,000
U18 · FY2019 · FD
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$737,877
T32 · FY2019 · GM
Mentoring in Clinical Pharmacology and Early Phase Trials$181,181
K24 · FY2019 · AI · contact PI
Global Pediatric Clinical Trials Network$1,000,000
U18 · FY2018 · FD
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program$696,677
T32 · FY2018 · GM
Global Pediatric Clinical Trials Network$1,000,000
U18 · FY2017 · FD
Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children$566,544
R01 · FY2017 · HD · contact PI
Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children$649,493
R01 · FY2016 · HD · contact PI
Phase I Clinical Trial to Evaluate a Neisseria Gonorrhoeae Therapeutic Candidate$204,339
N01 · FY2016 · AI · contact PI
Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children$676,893
R01 · FY2015 · HD · contact PI
Phase I Clinical Trial to Evaluate a Neisseria Gonorrhoeae Therapeutic Candidate$298,404
N01 · FY2015 · AI · contact PI
Phsysiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children-Informationist Supplement$39,631
R01 · FY2015 · HD · contact PI
Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children$621,379
R01 · FY2014 · HD · contact PI
Clinical Practice Data to Aid Narrow Therapeutic Index Drug Classification$249,895
U01 · FY2014 · FD · contact PI
Clinical Practice Data to Aid Narrow Therapeutic Index Drug Classification$247,024
U01 · FY2013 · FD · contact PI
Pharmacokinetics and Pharmacodynamics of Antibiotics in Premature Infants$120,003
K23 · FY2013 · HD · contact PI
Pharmacokinetics and Pharmacodynamics of Antibiotics in Premature Infants$120,665
K23 · FY2012 · HD · contact PI
Pharmacokinetics and Pharmacodynamics of Antibiotics in Premature Infants$118,276
K23 · FY2011 · HD · contact PI
Pharmacokinetics and Pharmacodynamics of Antibiotics in Premature Infants$115,474
K23 · FY2010 · HD · contact PI